Science & Enterprise subscription

Follow us on Twitter

  • Genny Cream for me, if I were there https://t.co/BQcWbr7yLh
    about 58 mins ago
  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 6 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 6 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 9 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago

Please share Science & Enterprise

Infographic – Greatest Human Health Risks

Human health risks ranked

Human health risks ranked. Click on image for full-size view. (Univ. of Chicago, Statista)

24 Nov. 2018. Biomedical research is the topic we cover the most on Science & Enterprise, driven by large-scale public and private investments in this field. These investments are often dictated by unmet medical needs and public health risks, and we’ve reported often on research into threats such as smoking, substance abuse, malaria, and HIV-AIDS.

It turns out the greatest current risk to the world’s health may be in the air we breathe. Earlier this week, a group at University of Chicago published its Air Quality Life Index, which our friends at Statista republished in graphic form, this weekend’s infographic. The data show air pollution, especially particulate pollution exceeding WHO guidelines, as the leading risk to public health, taking 1.8 years off of our average life expectancy. Smoking is not far behind at 1.6 years.

Cities in China and India receive the most attention about this problem, but the recent wildfires in Northern California are also taking a toll on air quality, including in the Bay area.

More from Science & Enterprise:

*     *     *

Comments are closed.